NasdaqGM - Delayed Quote USD

SIGA Technologies, Inc. (SIGA)

8.76 +0.41 (+4.91%)
At close: April 23 at 4:00 PM EDT
8.85 +0.09 (+1.01%)
After hours: April 23 at 6:35 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Daniel J. Luckshire Executive VP, CFO & Secretary 1.38M -- 1971
Dr. Dennis E. Hruby Executive VP & Chief Scientific Officer 1.41M -- 1952
Dr. Jay K. Varma M.D. Executive VP, Chief Medical Officer & Director 6.24k -- 1972
Ms. Tove C. Bolken Senior VP of Operations & Chief Supply Chain Officer -- -- --
Mr. Herb Vloedman Senior VP & Chief Information Officer -- -- --
Mr. Lawrence R. Miller Esq., J.D. General Counsel -- -- --

SIGA Technologies, Inc.

31 East 62nd Street
New York, NY 10065
United States
212 672 9100 https://www.siga.com
Sector: 
Healthcare
Full Time Employees: 
45

Description

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Corporate Governance

SIGA Technologies, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 7. The pillar scores are Audit: 8; Board: 9; Shareholder Rights: 2; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Apr 11, 2024
    Dividend Date
  • Apr 01, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing
  • Mar 25, 2024
    Ex-Dividend Date
  • Mar 12, 2024
    10-K: Periodic Financial Reports
    See Full Filing
  • Jan 22, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing

Upcoming Events

Feb 29, 2024 - Mar 04, 2024
SIGA Technologies, Inc. Earnings Call

Related Tickers

EBS Emergent BioSolutions Inc.
2.2900
+6.02%
 
LNTH Lantheus Holdings, Inc.
64.41
+2.12%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.3880
+0.26%
 
AQST Aquestive Therapeutics, Inc.
4.2800
-2.28%
 
SNOA Sonoma Pharmaceuticals, Inc.
0.1590
+1.02%
 
ETON Eton Pharmaceuticals, Inc.
3.2800
+0.92%
 
COLL Collegium Pharmaceutical, Inc.
35.94
+3.45%
 
ESPR Esperion Therapeutics, Inc.
2.0900
+9.42%
 
AMPH Amphastar Pharmaceuticals, Inc.
40.91
+1.84%
 
IRWD Ironwood Pharmaceuticals, Inc.
8.31
+3.10%